Oral histoplasmosis in Brazil

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Jun;93(6):654-9. doi: 10.1067/moe.2002.122588.

Abstract

Objective: We report 10 cases of histoplasmosis with oral manifestations seen in a teaching hospital in Brazil.

Study design: This is a retrospective study of the sociodemographic, clinicopathologic, and treatment data of these cases.

Results: Overall, 8 of 10 cases were seropositive for human immunodeficiency virus (HIV), whereas 2 were negative. The predominant oral manifestations found in HIV-seropositive patients were ulcers, oral pain, and odynophagia; both of the HIV-seronegative patients were symptom-free. HIV infection was suspected in 7 cases because of the presence of oral lesions of histoplasmosis. Asthenia, fever, weight loss, lymphadenopathy, and hepatosplenomegaly were found only in HIV-seropositive patients. Radiographs in 3 out of 10 patients suggested pulmonary involvement. Amphotericin B was the antifungal therapy chosen, and clinical remission of oral lesions occurred in an average of 30 days (accumulated doses: 500-1500 mg). Itraconazole was very effective as a follow-up treatment in terms of prevention of recurrence.

Conclusion: Histoplasmosis only rarely affects HIV-seronegative patients; however, the possibility of hidden immunodepression should be considered when oral manifestations of histoplasmosis are present.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections* / pathology
  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Brazil
  • Female
  • HIV Seropositivity / complications
  • Histoplasmosis / complications*
  • Histoplasmosis / drug therapy
  • Histoplasmosis / pathology
  • Humans
  • Itraconazole / therapeutic use
  • Male
  • Middle Aged
  • Mouth Diseases / complications*
  • Mouth Diseases / drug therapy
  • Mouth Diseases / pathology
  • Retrospective Studies

Substances

  • Antifungal Agents
  • Itraconazole
  • Amphotericin B